Artificial intelligence (AI) is here to stay. What concrete AI and Extended Reality (XR) applications already exist in practice? How can these technologies be successfully integrated into companies and what added value can they actually create? The What’s Next Forum @ Google Europaallee Zurich on November 7, 2024, will bring clarity. Here, [...] Premiere: What’s Next Forum Zurich – AI and XR in practice
A guest contribution by S. Maier, Ulm In the case of pre-hospital cardiac arrest (out-of-hospital cardiac arrest, OHCA), establishing vascular access as part of resuscitation and administering, among other things, adrenaline are standard procedures. Guidelines primarily recommend establishing intravenous (IV) vascular access and considering switching to an intraosseous (IO) access route if the attempt is unsuccessful. [...] Intraosseous vs. intravenous access in out-of-hospital cardiac arrest
Joachim Koppenberg, Christian Both, and Urs Pietsch have published a new book with cases in preclinical emergency medicine at Elsevier Verlag: Diagnoses and guidelines based on case examples for preclinical operations Exciting case examples from preclinical emergency medicine show the 61 most common and important operational diagnoses and the guideline-compliant procedure. The book supports structured and competent preparation for [...] New book on preclinical emergency medicine
The citizen service of the city of Schwerin is currently only available to a limited extent due to an increased number of sick employees. The city administration reports that fewer appointments are available for online booking, and next Monday, October 21st, which is usually appointment-free, will also offer a limited number of waiting tokens. On Saturday, October 19th, only [...] High number of sick employees in the city hall leads to severe restrictions – online services recommended.
Hattingen/Ennepe-Ruhr-Kreis - The outbreak of American foulbrood in a farm in Hattingen necessitates the establishment of a restricted zone. This zone is located in the Welper district and has a radius of approximately one kilometer around the affected farm. A map showing the restricted zone can be found in the general decree published by the Ennepe-Ruhr-Kreis veterinary office. The decree [...] FOULBROOD OUTBREAK IN HATTINGEN
According to a preclinical study by researchers at Weill Cornell Medicine, it may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy. The study, published on October 17 in Molecular Cell, provides new insights into a protein pair called p62 and NBR1 and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver's fight against tumors. The study shows that high concentrations of the immunosuppressive NBR1 in these specialized cells can identify patients who are unlikely to respond to immunotherapies. It also shows that strategies to lower NBR1 help shrink tumors in animal models, suggesting a potential new therapeutic approach for the subgroup of patients who do not respond to immunotherapies. "P62 and NBR1 are yin and yang," said the study's co-lead, Dr. Jorge...
(Toronto, October 18, 2024)" A new study in JMIR XR and Spatial Computing, published by JMIR Publications, identifies potential cybersecurity and privacy risks associated with the use of Extended Reality (XR) in healthcare. The study, titled “Cybersecurity and Privacy Concerns With Extended Reality Applications in Healthcare: A Scoping Review,” examines the identified potential threats posed by XR technology and strategies to mitigate these risks. The scoping review found few studies specifically addressing cybersecurity in the context of XR use in healthcare. Of the 29 studies examined, only 3 described healthcare applications or services, highlighting a critical research gap. Information disclosure – where personal and health-related data could leak, potentially compromising patient confidentiality – was identified as the greatest potential threat when using XR systems in healthcare. Although various risk mitigation strategies were identified…
A study by the Helmholtz Centre for Environmental Research (UFZ) provides the first evidence that chemicals in the human body can have neurotoxic effects even when present in amounts below the threshold of effect when considered individually. The scientists strongly advocate for a rethink in risk assessment. Instead of considering individual indicator substances, we must “think in chemical mixtures,” says Prof. Beate […] Chemical mixture damages nerves
According to Pugnalom, Saudi Arabia is making massive investments in environmental technologies, driving its economic diversification. The desert state is focusing on renewable energy, climate technologies, and innovative environmental solutions. Investments in Climate TechnologiesAccording to a study by venture data company MAGNiTT, Saudi Arabia attracted a total of $68 million in venture capital investments for climate technology startups… Saudi Arabia: Massive investments in environmental technologies
If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment with Kisqali® (ribociclib) in combination with an aromatase inhibitor. Recommendation is based on the Phase III NATALEE trial, where Kisqali added to endocrine therapy (ET) significantly reduced the risk of recurrence by 25% versus ET alone across a broad population of patients with HR+/HER2- early breast cancer. People with stage II or III HR+/HER2- EBC face significant risk of recurrence – often as incurable metastatic disease – despite adjuvant ET and regardless of nodal involvement. In September, Kisqali was approved by the FDA in this setting5; at ESMO 2024, an updated analysis from NATALEE was presented, showing a deepening invasive disease-free survival benefit. Kisqali® (ribociclib) is a selective cyclin-dependent…
